1、 This report draws from Drug Certification of Mexico in 1998: Arguments For and Against1Congressional Resolutions of Disapproval, CRS Report 98-272, March 20, 1998, by (name redacted). For tracking legislative action, see Mexican Drug Certification Issues: U.S. CongressionalAction, 1986-1999, CRS Re
2、port 98-174 F; and Mexico-U.S. Relations: Issues for Congress, CRSIssue Brief 97028, by (name redacted). For details on the certification process, sanctions, an dwaivers, see Mexico and Drug Certification in 1999: Consequences of Decertification, CRSReport RL30080, March 4, 1999, by (name redacted).
3、 For details on Mexican counter-narcoticsefforts in Zedillos presidency, see Mexicos Counter-Narcotics Efforts Under Zedillo, December1994 to March 1999, CRS Report RL30098, March 18, 1999, by (name redacted). Congressional Research Service The Library of CongressCRS Report for CongressReceived thro
4、ugh the CRS WebOrder Code RS20127Updated March 30, 1999Drug Certification of Mexico in 1999: Arguments For and Against Congressional Resolutions of Disapproval(name redacted)Specialist in Latin American AffairsForeign Affairs, Defense, and Trade DivisionSummaryThis report presents arguments for and
升级VIP 